Compare Neurocrine Biosciences Inc (NBIX) vs WD 40 Company (WDFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs WD 40 Company — how do they compare? Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B), while WD 40 Company trades at $233.59 (market cap $3.13B). The key difference: Neurocrine Biosciences Inc is far larger — about 5.3× WD 40 Company's market cap, and WD 40 Company pays a 1.75% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| NBIX | WDFC | |
|---|---|---|
Market Cap | $16.46B | $3.13B |
Sector | Health | Technology |
52-Week High | $185.50 | $264.91 |
52-Week Low | $123.10 | $187.52 |
Enterprise Value | $16.48B | $3.18B |
Dividend Yield | — | 1.75% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About WD 40 Company
WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →
